Form4insider filings, from the source

SEC Form 4/A · accession 0001493152-17-010371

GALECTIN THERAPEUTICS INC · GALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
Sep 30, 2016
Accepted (ET)
Sep 8, 2017 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Sep 30, 2016J92,451$1.13D3,377,359IBy 10X Fund, LP
Common StockF2,F3Sep 30, 2016J164,110$1.13D3,213,249IBy 10X Fund, LP
Common StockF2,F3Sep 30, 2016J484,036$1.13D2,729,213IBy 10X Fund, LP
Common StockF2,F3Sep 30, 2016J17,295$1.13D2,711,918IBy 10X Fund, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses